육미지황환이 GPNMB 발현을 조절하여 자가포식을 향상시키고 알츠하이머병을 방지하는 분자 메커니즘

  • role: First author第一作者
  • Affiliation:

    College of Basic Medicine, Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847,China

  • Email:751107629@qq.com
  • Introduction:刘羽茜,博士,讲师,从事中医药防治代谢性疾病分子机制研究,E-mail:751107629@qq.com
LIU Yuxi1,  
  • Affiliation:

    College of Basic Medicine, Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847,China

ZHU Zhongkang1,  
  • Affiliation:

    College of Basic Medicine, Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847,China

WANG Songnan1,  
  • Affiliation:

    College of Basic Medicine, Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847,China

LIU Jiali1,  
  • Affiliation:

    First Affiliated Hospital of Liaoning University of TCM, Shenyang 110847,China

YIN Ye2,  
  • Affiliation:

    College of Basic Medicine, Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847,China

MIAO Jiarui1,  
  • Affiliation:

    Teaching and Experimental Center,Liaoning University of TCM,Shenyang 110847,China

HE Shunuo3,  
  • role: Corresponding author通信作者
  • Affiliation:

    College of Basic Medicine, Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847,China

  • Email:danyu1978@163.com
  • Introduction:赵丹玉,博士,教授,从事中医药防治代谢性疾病分子机制研究,E-mail:danyu1978@163.com
ZHAO Danyu1*

추상적인

본 연구의 목적은 육미지황환이 당단백질 비전이성 흑색종 단백질 B(GPNMB)의 발현을 조절하여 급속 노화 생쥐(SAMP8)의 해마 자가포식 기능에 미치는 영향을 연구하고, 보신보정법이 알츠하이머병(AD) 치료에 미치는 작용 기전을 탐구하는 것이다. 방법: 실험 1에서는 5개월령 SAMP8 생쥐 24마리를 모델군과 육미지황환 저중고용량군(0.59, 1.18, 2.36 g·kg-1)으로 무작위 균등 분할하였으며, 동기간 항노화 생쥐(SAMR1) 6마리를 정상군으로 사용하였다. 신물체 인지 실험으로 학습 기억 능력을 평가하였고, 효소결합면역흡착법(ELISA)으로 혈청 코르티솔(Cort), 부신피질자극호르몬(ACTH) 및 소변 17-하이드록시코르티코스테로이드(17-OHCS) 수준을 측정하였다. 투과전자현미경으로 해마 신경세포의 초미세구조를 관찰하고, 웨스턴 블롯법으로 해마 조직의 GPNMB, ADAM10, 자가포식 관련 단백질 발현을 검출하였다. 실험 2에서는 SAMP8 생쥐 18마리를 모델군, 벡터 대조군(Vector), GPNMB 과발현군(GPNMBOE)으로 무작위 배정하고, 뇌 입체위치 주입법으로 렌티바이러스(각 측 2 μL)를 주입하여 웨스턴 블롯으로 목표 단백질 발현을 확인하였다. 실험 3에서는 SAMP8 생쥐 24마리를 모델군, 육미지황환 군, 육미지황환+음성 대조군(NC), 육미지황환+GPNMB 침묵군(shGPNMB)으로 무작위 배정하고, 약물 치료 전 음성 대조군 또는 GPNMB 침묵 렌티바이러스를 주입하여 웨스턴 블롯으로 발현을 측정하였다. 결과: 정상군과 비교하여 모델군 생쥐의 신물체 변별 지수가 유의하게 감소하였다(P<0.01); 모델군과 비교하여 육미지황환 중·고용량군에서 신물체 변별 지수가 유의하게 증가하였다(P<0.01); 투과전자현미경 관찰에서 정상군 해마 조직에서는 집적된 자가포식용해체가 관찰되었으며, 모델군에서는 주로 미토콘드리아가 관찰되고 전형적인 자가포식소체는 관찰되지 않았다; 육미지황환 저중용량군에서는 소량의 자가포식용해체 및 이중막 자가포식소체가 관찰되었고, 고용량군에서는 저중용량군보다 자가포식소체 및 자가포식용해체 수가 많았다; ELISA 및 웨스턴 블롯 결과 정상군과 비교하여 모델군에서 혈청 Cort, ACTH 및 소변 17-OHCS 수치가 유의하게 상승하였고, 해마 조직에서 ADAM10, Beclin1, 미세관 관련 단백질 경쇄 3Ⅱ/Ⅰ(LC3Ⅱ/Ⅰ) 발현은 유의하게 감소하였으며, GPNMB 및 유비퀴틴 결합 단백질 p62 발현은 뚜렷하게 상승하였다(P<0.05, P<0.01); 모델군과 비교하여 육미지황환 저중고용량군에서 혈청 Cort, ACTH 수치가 유의하게 감소하였고, 17-OHCS 수치는 고용량군에서만 유의하게 감소하였으며, 해마 조직에서 GPNMB, ADAM10, Beclin1, LC3Ⅱ/Ⅰ 발현이 유의하게 증가하고 p62 발현은 유의하게 감소하였다(P<0.01); GPNMBOE군은 모델군과 비교하여 GPNMB, ADAM10, Beclin1, LC3Ⅱ/Ⅰ 발현이 유의하게 증가하고 p62 발현이 유의하게 감소하였다(P<0.01); 육미지황환군은 해마에서 GPNMB, ADAM10, Beclin1, LC3Ⅱ/Ⅰ 발현이 유의하게 증가하고 p62 발현이 유의하게 감소하였으며(P<0.01), 육미지황환+shGPNMB군은 육미지황환군과 비교하여 GPNMB, ADAM10, Beclin1, LC3Ⅱ/Ⅰ 발현이 유의하게 감소하고 p62 발현은 유의하게 증가하였다(P<0.01). 결론: 육미지황환은 GPNMB 발현을 상향 조절하여 해마 자가포식 기능을 향상시키고 AD를 개선할 수 있다.

키워드

알츠하이머병; 육미지황환; 당단백질 비전이성 흑색종 단백질 B(GPNMB); 자가포식; 보신보정

References

  1. 1.
    YANG W M,XIE W T,LI X.Diagnosis and treatment standard for dementia (Alzheimer's disease) in traditional Chinese medicine[J].Clin J Tradit Chin Med,2023,35(7):1448-1451.
  2. 2.
    ZHU Z K,LIU Y X,WANG B,et al.Effect of Liuwei Dihuang pill-containing serum on autophagy induced by Aβ in SH-SY5Y cells and its mechanism[J].World Sci Tech Mod Tradit Chin Med,2022,24(2):670-677.
  3. 3.
    XIAO M,ZHANG X L,LIU W,et al.Progress of clinical and pharmacological mechanisms of kidney-tonifying formula for the treatment of Alzheimer's disease[J].Tradit Chin Drug Res Clin Pharmacol,2024,35(10):1628-1636.
  4. 4.
    RAO G L.Clinical observation of Liuwei Dihuang pill on kidney yin deficiency syndrome in Alzheimer's disease[D].Changsha:Hunan University of Chinese Medicine,2024.
  5. 5.
    HOU W X,SI R H,LIU Y X,et al.Molecular mechanism of Liuwei Dihuang pill in preventing Alzheimer's disease by regulating FcγRIIB/c-Src pathway and autophagy[J].World Sci Tech Mod Tradit Chin Med,2025,27(3):724-738.
  6. 6.
    ZHU Z K,ZHANG L,LIU C,et al.Intervention effect of kidney-tonifying and essence-filling therapy on hippocampal autophagy in kidney-deficiency Alzheimer mice[J].Chin J Exp Tradit Med Form,2019,25(20):43-48.
  7. 7.
    ZHU Z K,LIU Y X,LI X Y,et al.GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal[J].Neurosci Lett,2022,767:136300.
  8. 8.
    ZHOU Q Y,XIA T J,LIU T T,et al.Research progress of immune cells involved in regulation of Alzheimer's disease[J].Chin J Immunol,2021,37(21):2653-2656,2663.
  9. 9.
    TANG R H.Effect of IL-4 on microglial autophagy and whether microglial polarization and phagocytosis depend on autophagy[D].Shenyang:China Medical University,2019.
  10. 10.
    TSOU P S,SAWALHA A H.Glycoprotein nonmetastatic melanoma protein B:A key mediator and an emerging therapeutic target in autoimmune diseases[J].FASEB J.2020,34(7):8810-8823.
  11. 11.
    KITANI A,MATSUI Y.Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease[J].Alzheimers Res Ther,2025,17(1):70.
  12. 12.
    LI X,XU J,SU W,et al.GPNMB modulates autophagy to enhance functional recovery after spinal cord injury in rats[J].Cell Transplant,2024,doi:.
  13. 13.
    XU Y,WANG M,ZHANG L,et al.Glycoprotein non-metastatic melanoma protein b restricts PRRSV replication by inhibiting autophagosome-lysosome fusion[J].Viruses,2023,15(4):920.
  14. 14.
    WANG G,QI J L,LIU X Y,et al.China Alzheimer report 2024[J].J Diagn Concepts Pract,2024,23(3):219-256.
  15. 15.
    WANG X,XU Y,GUAN Y N,et al.Effect of Shudihuang (Rehmanniae Radix Praeparata)-Shanzhuyu (Corni Fructus) herb pair on N2a cell apoptosis induced by Aβ25-35 through PI3K/Akt signaling pathway[J].Liaoning J Tradit Chin Med,2024,51(2):151-154,226.
  16. 16.
    ZHANG F,LI J,SUN T L.Research progress in neurotoxicity mechanism of β-amyloidosis[J].J Wuhan Univ Technol,2018,40(11):29-35,44.
  17. 17.
    CHEN Y Q,YANG J,PEI W L,et al.Regulatory effect of Hei Xiaoyaosan on cognitive impairment and gut microbiota in APP/PS1 mice[J].Chin J Exp Tradit Med Form,2025,31(19):191-201.
  18. 18.
    HOU W X,LIU Y X,MIAO J R,et al.Mechanism of Liuwei Dihuangwan in enhancing GPNMB expression to regulate FcγRⅡB/c-Src pathway for prevention and treatment of Alzheimer's disease[J].China J Chin Mater Med,2025,50(21):6062-6071.
  19. 19.
    PACESOVA A,HOLUBOVA M,HRUBA L,et al.Age-related metabolic and neurodegenerative changes in SAMP8 mice[J].Aging (Albany NY),2022,14(18):7300-7327.
  20. 20.
    CHEN X Y,GUO L,ZHANG J L,et al.Study on intervention effect of Rehmanniae decoction on Parkinson's disease model rats with kidney-deficiency syndrome and its mechanism[J].Yunnan J Tradit Chin Med Mater Med,2018,39(3):72-75.
  21. 21.
    WANG H M,SONG C M,LIU X M,et al.Effects of Liuwei Dihuang Wan on animal senile dementia models with deficiency of the kidney[J].Chin J Exp Tradit Med Form,2012,18(5):112-116.
  22. 22.
    HE W B,ZHANG J L,CHEN N H.Analysis of relationship between brain and kidney of TCM based on negative feedback regulation in hippocampus-HPA axis[J].China J Tradit Chin Med Pharm,2016,31(9):3426-3428.
  23. 23.
    SHOU Q Y,ZHANG L Z,CAI Y Q,et al.Kidney yang deficiency constitution and hypothalamic-pituitary-adrenal axis dysfunction in Lewis rats[J].Chin J Comp Med,2015,25(9):8-13,38.
  24. 24.
    WANG X Q.Exploring the mechanism of Yishen Yangxin Anshen tablets on learning and memory impairments in insomnia stress model rats:A study based on the HPA Axis pathway[D].Chengde:Chengde Medical College,2024.
  25. 25.
    SUI X.Orally long-term administration of acarbose impacts the age effects on levels of synaptotagmin Ⅰ and GFAP in dorsal hippocampus of mice[D].Hefei:Anhui Medical University,2014.
  26. 26.
    LI D Y,AI M,ZHOU P,et al.Construction and evaluation of syndrome-combined mouse model of kidney deficiency Alzheimer's disease[J].Pharmacol Clin Chin Mater Med,2025,41(5):102-109.
  27. 27.
    ZHANG X W,ZHU X X,TANG D S,et al.Targeting autophagy in Alzheimer's disease:Animal models and mechanisms[J].Zool Res,2023,44(6):1132-1145.
  28. 28.
    ZHANG Z,YANG X,SONG Y Q,et al.Autophagy in Alzheimer's disease pathogenesis:Therapeutic potential and future perspectives[J].Ageing Res Rev,2021,doi:.
  29. 29.
    HUANG C.The effects of GPNMB in promoting the repair of peripheral nerve injury and its mechanism[D].Shanghai:Naval Medical University,2019.
  30. 30.
    GILLETT D A,WALLINGS R L,URIARTE HUARTE O,et al.Progranulin and GPNMB:Interactions in endo-lysosome function and inflammation in neurodegenerative disease[J].J Neuroinflammation,2023,20(1):286.
  31. 31.
    YARBRO J M,SHRESTHA H K,WANG Z,et al.Proteomic landscape of Alzheimer's disease:Emerging technologies,advances and insights (2021-2025)[J].Mol Neurodegener,2025,20(1):83.
  32. 32.
    MARTINS-FERREIRA R,CALAFELL-SEGURA J,LEAL B,et al.The human microglia atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions[J].Nat Commun,2025,16(1):739.
  33. 33.
    ROSE A A,ANNIS M G,DONG Z,et al.ADAM10 releases a soluble form of the GPNMB/osteoactivin extracellular domain with angiogenic properties[J].PLoS One,2010,5(8):e12093.
  34. 34.
    MOU L W,HAN P,YANG Y J.Exercise intervention alleviating learning and memory dysfunction of Alzheimer's disease model mice through modulating autophagy of hippocampal neurons[J].Acta Anat Sin,2024,55(5):533-540.
  35. 35.
    ZHANG Y N,LU H F,WANG P,et al.Shenghui granules improve learning memory in Alzheimer's disease mice by inhibiting PI3K/Akt/mTOR signaling pathway[J].Chin J Integr Tradit West Med,2024,44(3):324-330.
  36. 36.
    KAGEYAMA,GUDMUNDSSON S R,SOU Y S,et al.p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response[J].Nat Commun,2021,12(1):16.
  37. 37.
    TAO X X,XIAO M,TANG K Y,et al.Exercise combined with Shenghui decoction intervention on M1AChR regulation of mitochondrial autophagy improves learning and memory ability in Alzheimer's disease model rats[J].Chin J Exp Tradit Med Form,2025,27(3):1-13.
  38. 38.
    CHOI I,ZHANG Y,SEEGOBIN S P,et al.Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration[J].Nat Commun,2020,11(1):1386.
  39. 39.
    HEGDEKAR N,SARKAR C,BUSTOS S,et al.Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes[J].Autophagy,2023,19(7):2026-2044.
  40. 40.
    WANG H,YE J,PENG Y,et al.CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction[J].Autophagy,2024,20(3):590-613.
  41. 41.
    WANG Z,WANG Q,LI S,et al.Microglial autophagy in Alzheimer's disease and Parkinson's disease[J].Front Aging Neurosci,2023,14:1065183.

더 읽기

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website